Weight-loss drug users may find themselves having to scale back. The Food and Drug Administration is cracking down on copycat versions of Ozempic — the brand name of semaglutide — and Zepbound — the brand name of tirzepatide, threatening a workaround that allowed patients to access cheaper alternatives during shortages. Thursday was the final cut-off…
A new once-daily pill may raise the bar for weight loss meds. Ozempic, Mounjaro and similar drugs that mimic the GLP-1 hormone the body naturally produces after eating can cause significant weight loss, but a potential side effect is loss of lean muscle mass. The makers of the experimental drug SYNT-101 claim it mimics the…
The Food and Drug Administration has approved the first at-home test for cervical cancer screening, its maker Teal Health said on Friday, offering an alternative to Pap smears that need to be undertaken at a doctor’s office. Pap smear tests have significantly reduced cancer incidence from when they were first introduced 80 years ago. But…
Heeding the call to ban artificial ingredients by Health and Human Services Secretary Robert F. Kennedy Jr., PepsiCo isn’t wasting any time getting started. Ramon Laguarta, PepsiCo Inc. chair and chief executive officer, said in an April 24 conference call that the company will reduce artificial ingredients and has already begun doing so, as Food Business News reported….
A 28-year-old man has revealed a harrowing nine-month struggle with a popular hair loss drug, describing the mostly sexual side effects that turned his life upside down. Shockingly, he says, the symptoms got even worse after he stopped taking it. Speaking on the podcast “Moral Medicine,” a man who goes by Chirag said he was…
